Roundtable Discussion: Overcoming Commercial & Clinical Challenges to Advance the Next-Generation of Obesity Therapeutics
- Balancing rapid weight loss with microvascular and metabolic health preservation to mitigate rebound effects and enhance reimbursement potential
- Understand regulatory and patient advocacy perspectives to improve trial retention
- Exploring ethical trial design for the next gen-generation of obesity therapies to provide robust evidence for regulatory and commercial success